logo
Sign in

HTSUF Stock Price, Chart, Stats & News

Hisamitsu Pharmaceutical Co., Inc.
Save
2.12B
Market cap
16.20x
Current P/E
Forward P/E
4.25%
Dividend yield

HTSUF chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Hisamitsu Pharmaceutical Co., Inc. is a Japanese enterprise that develops and markets a range of pharmaceuticals, quasi-drugs, and medical devices. Its extensive product catalog includes popular external pain relief solutions such as SALONPAS, NOBINOBI, SALONSIP, AIR, and FEITAS. The company also provides targeted treatments like BUTENALOCK for athlete's foot and ALLEGRA FX, a medication addressing sinus and allergy symptoms.

Similar securities

Based on sector and market capitalization

Report issue